(VNDA) Vanda Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Vanda Pharmaceuticals | (VNDA) share price targets
Complete technical analysis of Vanda Pharmaceuticals (VNDA) by charts plus indicators, forecast predictions and share price targets for Vanda Pharmaceuticals (VNDA)
Vanda Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-24 View latest technical analysis
10 day averaged volume of Vanda Pharmaceuticals is 965490
Date | Daily Closing Price | Open | High | Low | Volume |
24 Thu Oct 2024 | 4.52 | 4.65 | 4.69 | 4.50 | 0.488 times |
23 Wed Oct 2024 | 4.69 | 4.67 | 4.72 | 4.63 | 0.347 times |
22 Tue Oct 2024 | 4.73 | 4.74 | 4.82 | 4.71 | 0.322 times |
21 Mon Oct 2024 | 4.73 | 4.93 | 4.93 | 4.73 | 0.403 times |
18 Fri Oct 2024 | 4.91 | 4.73 | 4.93 | 4.68 | 0.674 times |
17 Thu Oct 2024 | 4.74 | 4.90 | 4.90 | 4.72 | 0.41 times |
16 Wed Oct 2024 | 4.90 | 4.84 | 4.98 | 4.80 | 0.512 times |
15 Tue Oct 2024 | 4.80 | 4.78 | 4.88 | 4.68 | 1.042 times |
14 Mon Oct 2024 | 4.81 | 5.07 | 5.30 | 4.77 | 5.804 times |
11 Fri Oct 2024 | 4.44 | 4.41 | 4.45 | 4.37 | 0.255 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 4.5 as stoploss in an intra day buy trade for a target of 4.64. However, stock will show a bearish move below 4.5.
Share price targets for Vanda Pharmaceuticals (VNDA)
Target Type | Value |
Downside Target | 4.35 |
Upside Target | 4.92 |
Upside Target | 5.05 |
Upside Target | 5.13 |
Upside Target | 5.30 |
Upside Target | 5.35 |
Upside Target | 5.97 |
Upside Target | 6.37 |
Upside Target | 6.75 |
Intraday share price targets for Vanda Pharmaceuticals (VNDA)
Target Type | Value |
Downside Intraday Target | 4.37 |
Downside Intraday Target | 4.22 |
Upside Intraday Target | 4.8 |
Upside Intraday Target | 5.08 |
Upside Intraday Target | 4.65 |
Weekly technical analysis of Vanda Pharmaceuticals (VNDA)
Date | Weekly Closing Price | Open | High | Low | Volume |
24 Thu Oct 2024 | 4.52 | 4.93 | 4.93 | 4.50 | 0.185 times |
18 Fri Oct 2024 | 4.91 | 5.07 | 5.30 | 4.68 | 7.269 times |
11 Fri Oct 2024 | 4.44 | 4.60 | 4.63 | 4.35 | 0.612 times |
04 Fri Oct 2024 | 4.63 | 4.63 | 4.74 | 4.46 | 0.62 times |
27 Fri Sep 2024 | 4.67 | 4.65 | 5.13 | 4.57 | 0.702 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Vanda Pharmaceuticals (VNDA)
Date | Monthly Closing Price | Open | High | Low | Volume |
24 Thu Oct 2024 | 4.52 | 4.69 | 5.30 | 4.35 | 1.021 times |
30 Mon Sep 2024 | 4.69 | 5.28 | 5.35 | 4.43 | 0.953 times |
30 Fri Aug 2024 | 5.29 | 5.86 | 5.97 | 5.05 | 0.767 times |
31 Wed Jul 2024 | 5.84 | 5.68 | 6.37 | 5.13 | 0.496 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Vanda Pharmaceuticals (VNDA)
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Vanda Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Vanda Pharmaceuticals in short term but the buy signal is initial and weak.
Vanda Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Vanda Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Vanda Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.78 and Vanda Pharmaceuticals (VNDA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Vanda Pharmaceuticals (VNDA) stock. Volume based technical analysis of Vanda Pharmaceuticals (VNDA) stock is negative.
Vanda Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Vanda Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Vanda Pharmaceuticals in short term but the buy signal is initial and weak.
Vanda Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Vanda Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Vanda Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.78 and Vanda Pharmaceuticals (VNDA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Vanda Pharmaceuticals (VNDA) stock. Volume based technical analysis of Vanda Pharmaceuticals (VNDA) stock is negative.
Vanda Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.